Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome
Authors
Keywords
aHUS, children, eculizumab, kidney disease, pediatric, thrombotic microangiopathy
Journal
KIDNEY INTERNATIONAL
Volume 89, Issue 3, Pages 701-711
Publisher
Elsevier BV
Online
2016-01-28
DOI
10.1016/j.kint.2015.11.026

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.